Last week, Johnson & Johnson reached a A$300 million settlement for two class actions brought by Australian women affected by complications from vaginal mesh products.

The products are surgically implanted to correct urinary incontinence or prolapse, where the vaginal tissues weaken and sag outside the vagina.

However,...